@prefix biolink: . @prefix dcterms: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix nkg: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { biolink:category biolink:Disease . sub:association rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; rdfs:label "However, other atypical antipsychotics, such as lurasidone, are often considered for off-label use in the treatment of irritability, whether because of tolerability issues with risperidone and aripiprazole or because of the drug-refractory nature of this symptom cluster."; biolink:association_type biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation; biolink:has_population_context sub:cohort; biolink:provided_by ; biolink:publications ; biolink:relation nkg:OffLabelIndication . sub:cohort rdfs:label "Children and adolescents"; biolink:category biolink:Cohort; biolink:has_phenotype . biolink:category biolink:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "F3u8v+B2DVgllbbcaNH8Cj/MupuR51Yo9wLvqzs2J9P6EjIORFqr4e1h97SeBQFXuO9JFDf3NQ8c3hJTFibDdkwLG5uDpFoQi3Og0MkStw+aNH0t7+kQNRghNkfMaRSdcMBy1OoYbjRZObncfJ/HUp0rkOCiaFt/didAXIsFqnQ="; npx:hasSignatureTarget this: . this: dcterms:created "2021-05-25T14:35:02.341+02:00"^^xsd:dateTime; dcterms:creator orcid:0000-0002-7641-6446; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }